CCORT - Emergent<unk>  Failure Mortality Risk Grade Calculator
7 day mortality risk score calculator for patients presenting to the ED with decompensated HF
https://ehmrg.ices.on.ca
AHCPR '00
ACS
Pulmonary edema/respiratory distress
O2 sat < 90% on room air
Severe complicating illness<unk>  refractory to outpatient therapy
Anasarca
Symptomatic hypotension or syncope
Arrhythmia (e.g. new a. fib)
Inadequate outpatient support
ACE inhibitor
Lisinopril 5mg QD start; 20mg QD goal
Captopril 25mg tid start; 100mg tid goal
Benazepril 10mg QD start; 40mg QD goal
ARB
Losartan 25mg BID start; 50mg BID goal
Valsartan 80mg QD start; 160mg QD goal
Beta-blocker
Carvedilol 3.125mg BID start; 25mg BID goal (50mg BID goal if weight > 85 kg)
Metoprolol ER 12.5mg QD start; 190mg QD goal
Others
Hydralazine/isosorbid dinitrate 10-20mg (1 tab) tid start; 100-80mg (5 tabs) goal for black patients with NYHA III-IV already on BB and ACEi
Spironolactone 25mg QD start; 50mg QD goal for indications:
LVEF < 30% with NYHA II
LVEF < 35% with NYHA III-IV
LVEF < 40% post-MI, goal ACE-I, symptomatic<unk> , or DM
Lisinopril 5mg QD start; 20mg QD goal
Captopril 25mg tid start; 100mg tid goal
Benazepril 10mg QD start; 40mg QD goal
Losartan 25mg BID start; 50mg BID goal
Valsartan 80mg QD start; 160mg QD goal
Carvedilol 3.125mg BID start; 25mg BID goal (50mg BID goal if weight > 85 kg)
Metoprolol ER 12.5mg QD start; 190mg QD goal
Hydralazine/isosorbid dinitrate 10-20mg (1 tab) tid start; 100-80mg (5 tabs) goal for black patients with NYHA III-IV already on BB and ACEi
Spironolactone 25mg QD start; 50mg QD goal for indications:
LVEF < 30% with NYHA II
LVEF < 35% with NYHA III-IV
LVEF < 40% post-MI, goal ACE-I, symptomatic<unk> , or DM
LVEF < 30% with NYHA II
LVEF < 35% with NYHA III-IV
LVEF < 40% post-MI, goal ACE-I, symptomatic<unk> , or DM
Congestive heart failure
Cardiovascular
Lung transplant complications
ACS
High-output heart failure
Acute Valve Dysfunction
Cirrhosis
Aortic Dissection